BioSpace News Archive

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Stuart A. Arbuckle has been appointed as the company’s Executive Vice President, Chief Operating Officer (COO), effective immediately.

IMV Inc. today announced that Frederic Ors has stepped down as Chief Executive Officer (CEO), effective immediately.

Cerus Corporation (Nasdaq: CERS) today announced the appointment of Ann Lucena, CEO of San Ramon Regional Medical Center (SRRMC), to its Board of Directors.

Perimeter Medical Imaging AI, Inc. today announced that Perimeter will participate in the 6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference.

Genesis Biotechnology Group announced today that it acquired the New Jersey -based Montclair Breast Center (MBC).

ReddyPort, a medical technology company focused on bringing new non-invasive ventilation (NIV) products into market, announced today that Jackson Hospital has selected ReddyPort™ Elbow in combination with ReddyPort™ NIV Maintenance products to help create a better care experience for patients on NIV without mask removal or interruption of (CPAP) or bi-level therapy.

Composition of Matter Patent Covers More than 80 Novel Compounds [04-August-2021] MELBOURNE, Australia , Aug. 4, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today announced the United States Patent and Tr

Alpha Pro Tech, Ltd., a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, announced financial results for the three and six months ended June 30, 2021.

OliX Pharmaceuticals, Inc. today presented preclinical data on OLX702A, an investigational therapeutic for the treatment of nonalcoholic steatohepatitis (NASH), at the 48th Korean Academy of Science and Technology (KAST) International Symposium.

IntelGenx Technologies Corp. (TSX V:IGX)(OTCQB:IGXT) (the “Company” or “IntelGenx”) today announced the appointments of Srinivas (Srini) G. Rao, M.D., Ph.D. and Frank Stegert to its Board of Directors.